Cambrex appoints Yanai as non-executive Vice Chairman

Cambrex appoints Yanai as non-executive Vice Chairman

5:02 AM, 30th November 2012
Cambrex appoints Yanai as non-executive Vice Chairman

EAST RUTHERFORD, US: Cambrex Corporation appointed Shlomo Yanai to its Board of Directors. He will serve as its non-executive Vice Chairman. Yanai, who retired in mid-2012 as the President and Chief Executive Officer of Teva Pharmaceutical Industries Ltd, has extensive experience in the life sciences industry. As Vice Chairman of the Cambrex Board, he will work closely with the company’s other directors and its leadership team to formulate and help execute Cambrex’s growth strategies.

“Shlomo’s outstanding background in the pharmaceutical industry will be a great asset to us as we continue to implement our strategic initiatives to grow sales of active pharmaceutical ingredients and finished dosage form products for the branded and generic markets,” said Steven M Klosk, President and CEO, Cambrex.

© WOC News

0 Comments

Login

Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News


Petronas selects INEOS’ Innovene G technology for LL/HDPE plant

KUALA LUMPUR, MALAYSIA: Petronas has selected INEOS Technologies’ Innovene G gas phase fluidised bed process for the linear low-density polyethy ...

Read more
Songwon Additive, Polysys to locate OPS plant in Abu Dhabi

ULSAN, KOREA: Songwon Additive Technologies AG and Polysys Industries will establish a new company Polysys Additive Technologies ME, which will build ...

Read more
Linde to supply gases to three Chinese flat panel display manufacturers

SHANGHAI, CHINA: Capitalizing on the growth of the display industry in China, the Linde Gases Division, part of Linde Group, has become a major suppli ...

Read more
Lonza sells US Brandenburg facility to Monument Chemical

BASEL, SWITZERLAND/INDIANAPOLIS, US: Lonza Group and Monument Chemical have signed a definitive agreement for sale of substantially all of the assets ...

Read more
Bayer supports pharmaceutical research in Europe

BERLIN, GERMANY: Bayer HealthCare and Leiden University of The Netherlands will coordinate a newly founded international consortium, dubbed ‘K4D ...

Read more
Grace completes acquisition of Noblestar Catalysts assets

QINGDAO, CHINA: W R Grace & Co completed acquisition of assets of Noblestar Catalysts Co Ltd, a Qingdao, China-based manufacturer of fluid catalyt ...

Read more